Technology | July 17, 2013

Hologic Launches 3-D Breast Biopsy Option

The Affirm 3-D biopsy procedure is designed for the localization and accurate targeting of regions of interest

 X0000 Hologic Affirm breast biopsy guidance system

July 17, 2013 — Hologic Inc. recently expanded its array of interventional and imaging solutions for breast health with the launch of the world's first 3-D breast biopsy option. This technology was developed for the company's Affirm upright breast biopsy guidance system, which is used in conjunction with the Selenia Dimensions 2-D and 3-D mammography systems.

The Affirm 3-D biopsy procedure is designed for the localization and accurate targeting of regions of interest and is especially important for targeting lesions not always detected in 2-D images or when using other modalities. This new biopsy technique has numerous advantages over traditional stereotactic biopsy procedures, including faster lesion targeting and reduced patient procedure time. In addition, the Affirm system is pre-programmed for use with the company's Eviva and ATEC vacuum-assisted breast biopsy devices, providing easy integration of these products.

In June 2013, Magee-Womens Hospital of UPMC became the first facility in the nation to perform a tomosynthesis biopsy. Dr. Jules Sumkin, D.O., chief of radiology at Magee, performed the Affirm 3-D biopsy procedure using the Eviva device. 

For more information: www.hologic.com

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...